Satellos Bioscience Inc.

TSX:MSCL Stock Report

Market Cap: CA$53.1m

Satellos Bioscience Balance Sheet Health

Financial Health criteria checks 5/6

Satellos Bioscience has a total shareholder equity of CA$29.2M and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$33.2M and CA$4.0M respectively.

Key information

0%

Debt to equity ratio

CA$0

Debt

Interest coverage ration/a
CashCA$27.70m
EquityCA$29.17m
Total liabilitiesCA$4.03m
Total assetsCA$33.19m

Recent financial health updates

Recent updates

We're Hopeful That Satellos Bioscience (TSE:MSCL) Will Use Its Cash Wisely

Apr 11
We're Hopeful That Satellos Bioscience (TSE:MSCL) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Satellos Bioscience's (CVE:MSCL) Cash Burn Situation

Dec 22
Here's Why We're Not Too Worried About Satellos Bioscience's (CVE:MSCL) Cash Burn Situation

Will Satellos Bioscience (CVE:MSCL) Spend Its Cash Wisely?

Apr 08
Will Satellos Bioscience (CVE:MSCL) Spend Its Cash Wisely?

Financial Position Analysis

Short Term Liabilities: MSCL's short term assets (CA$29.2M) exceed its short term liabilities (CA$4.0M).

Long Term Liabilities: MSCL has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: MSCL is debt free.

Reducing Debt: MSCL had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: MSCL has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: MSCL has less than a year of cash runway if free cash flow continues to reduce at historical rates of 54.7% each year


Discover healthy companies